Press release

Finalists announced for the Most innovative European Biotech SME Awards 2017

Brussels, 18 October 2017 – EuropaBio, the European Association for Bioindustries, today announces the finalists for 8th edition of the Most Innovative European Biotech SME Awards, a unique annual initiative which recognises innovative biotech SMEs and the crucial role they play in answering some of society’s greatest challenges.

There were 25 small and medium biotech companies in contention for this year’s awards, with five of them shortlisted by the Jury to compete across three categories: healthcare, industrial and agricultural biotechnology. They will be showcased during a pitching session, followed by an awards ceremony hosted by Awards Jury Member and MEP Paul Rubig at the European Parliament in Brussels on 22 November.

“Apart from the strength and innovation of each applicant this year, we are proud that EuropaBio’s Awards continue to attract biotech leaders and champions for innovation and SMEs in Europe on the Jury. We are honoured and grateful to Dame Anne Glover[1], Peter Heinrich[2], MEP Paul Rubig[3] and Frank Bulens[4] for the time, energy and dedication invested in this year’s awards,” said EuropaBio Secretary General and Jury Member John Brennan.

EuropaBio SME Platform Chair Peter Heinrich added ‘the diversity and quality of applications we received this year bears witness not only to the success of entrepreneurial biotech in Europe but to the exceptional diversity of innovation among European biotech SMEs. The jury and I were very much inspired by the amazing research, products and business prowess shown by Europe’s leading biotech SMEs, and we hope that through these awards we put the strongly deserved spotlight on their work and potential.’

The five shortlisted SMEs are:

Healthcare or Red Biotech Category

Nightingale Health is a Finnish biotechnology company addressing chronic diseases with a proprietary blood analysis platform that can improve risk prediction of, among others, cardiovascular diseases and diabetes. With headquarters and laboratory facilities in Finland, along with two franchising laboratories in the UK, they routinely provide services for academic research customers internationally. With clinical pilots ongoing, the company’s next major milestone is to bring its blood analysis service to healthcare providers globally. Ultimately, Nightingale aims to make preventative healthcare in chronic diseases available for everyone.

NovaBiotics is a UK-based clinical-stage biotechnology company focused on the design and development of first-in-class anti-infectives for difficult-to-treat, medically unmet diseases. A leading innovator in the anti-infectives space, the company’s robust technology and business model has been validated through successful development, from concept to clinic, of two lead products and securing the most appropriate commercial collaborations to enable the delivery of these highly promising therapy candidates to markets of significant worth.

Industrial or White Biotech Category

Carbios is a French green chemistry company focused on discovering and developing enzymatic bioprocesses to reinvent the lifecycle of plastics. By combining enzymology and plasturgy, a novel industrial approach, Carbios brings a major change to the way that plastics are produced and consumed. The company’s processes are based on the use of enzymes produced by natural microorganisms selected for their ability to degrade the polymers that make up plastic materials.

Numaferm is a German spin-off company from the Institute of Biochemistry of the Heinrich-Heine-University in Düsseldorf that has developed a reliable, cost-efficient technology to manufacture peptides based on well-designed microorganisms that convert simple nutrients to peptides. Peptides are biomolecules with unique characteristics and functionalities – for example pharmaceutical, antimicrobial or adhesive.

Agricultural or Green Biotech Category

Iden Biotechnology is a Spanish company developing biotech products and integrated solutions for crop yield and quality enhancement, including agrobiological products (e.g. plant biostimulants and biopesticides), and more productive crop varieties. Their products are part of the general industry of farm inputs and, within that, the broad sectors of seeds and crop protection.

Media contact: Cosmin Popa, EuropaBio Communications and National Associations Manager, Email: / Telephone: +32 2 739 11 73 / Mobile: +32 499 906 129

[1] Vice Principal for External Affairs and Dean for Europe at the University of Aberdeen, former Chief Scientific Adviser to the President of the European Commission

[2] Serial entrepreneur and Chair of the EuropaBio SME Platform and Bio Deutschland, Managing Director and Partner at Sinfonie Life Science Management GmbH, Partner of Alirahealth; Chairman of the Board of Directors at Syntba GmbH

[3] Member of the European Parliament’s Committee on Industry, Research and Energy and the Committee on Budgets, and very active in the field of the small-scale business promotion

[4] Member of the Management Committee and Board of Directors of Capricorn Venture Partners